Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.0051 | 0.9 |